Additionally, EV RNA sequencing revealed an enrichment of miRNAs, targeting different molecules linked to cancer progression (e.g., cyclin-dependent kinase (CDK) family: CDK2, CDK4, and CDK6) and cancer-survival signalling (PIK3R, RAS, MAPK, and STAT). This evidence concerns the gene CDK4 and cancer.